BHVN
Price
$36.17
Change
+$0.83 (+2.35%)
Updated
Dec 20, 04:59 PM (EDT)
89 days until earnings call
PLX
Price
$1.75
Change
+$0.01 (+0.57%)
Updated
Dec 20, 04:59 PM (EDT)
82 days until earnings call
Ad is loading...

BHVN vs PLX

Header iconBHVN vs PLX Comparison
Open Charts BHVN vs PLXBanner chart's image
Biohaven
Price$36.17
Change+$0.83 (+2.35%)
Volume$19.99K
CapitalizationN/A
Protalix BioTherapeutics
Price$1.75
Change+$0.01 (+0.57%)
Volume$1.99K
CapitalizationN/A
BHVN vs PLX Comparison Chart
Loading...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHVN vs. PLX commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHVN is a Hold and PLX is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (BHVN: $36.26 vs. PLX: $1.76)
Brand notoriety: BHVN and PLX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BHVN: 340% vs. PLX: 91%
Market capitalization -- BHVN: $3.67B vs. PLX: $129.6M
BHVN [@Biotechnology] is valued at $3.67B. PLX’s [@Biotechnology] market capitalization is $129.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHVN’s FA Score shows that 0 FA rating(s) are green whilePLX’s FA Score has 0 green FA rating(s).

  • BHVN’s FA Score: 0 green, 5 red.
  • PLX’s FA Score: 0 green, 5 red.
According to our system of comparison, PLX is a better buy in the long-term than BHVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHVN’s TA Score shows that 3 TA indicator(s) are bullish while PLX’s TA Score has 4 bullish TA indicator(s).

  • BHVN’s TA Score: 3 bullish, 5 bearish.
  • PLX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PLX is a better buy in the short-term than BHVN.

Price Growth

BHVN (@Biotechnology) experienced а -5.74% price change this week, while PLX (@Biotechnology) price change was -2.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

BHVN is expected to report earnings on Mar 20, 2025.

PLX is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHVN($3.67B) has a higher market cap than PLX($130M). PLX YTD gains are higher at: -1.124 vs. BHVN (-15.280). PLX has higher annual earnings (EBITDA): -6.48M vs. BHVN (-841.6M). BHVN has more cash in the bank: 379M vs. PLX (27.4M). PLX has less debt than BHVN: PLX (5.68M) vs BHVN (29M). PLX has higher revenues than BHVN: PLX (45.7M) vs BHVN (0).
BHVNPLXBHVN / PLX
Capitalization3.67B130M2,821%
EBITDA-841.6M-6.48M12,998%
Gain YTD-15.280-1.1241,360%
P/E RatioN/A13.00-
Revenue045.7M-
Total Cash379M27.4M1,383%
Total Debt29M5.68M510%
FUNDAMENTALS RATINGS
BHVN vs PLX: Fundamental Ratings
BHVN
PLX
OUTLOOK RATING
1..100
6287
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9995
PRICE GROWTH RATING
1..100
6338
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PLX's Valuation (62) in the Servicestothe Health Industry industry is in the same range as BHVN (72) in the Pharmaceuticals Major industry. This means that PLX’s stock grew similarly to BHVN’s over the last 12 months.

PLX's Profit vs Risk Rating (100) in the Servicestothe Health Industry industry is in the same range as BHVN (100) in the Pharmaceuticals Major industry. This means that PLX’s stock grew similarly to BHVN’s over the last 12 months.

PLX's SMR Rating (95) in the Servicestothe Health Industry industry is in the same range as BHVN (99) in the Pharmaceuticals Major industry. This means that PLX’s stock grew similarly to BHVN’s over the last 12 months.

PLX's Price Growth Rating (38) in the Servicestothe Health Industry industry is in the same range as BHVN (63) in the Pharmaceuticals Major industry. This means that PLX’s stock grew similarly to BHVN’s over the last 12 months.

PLX's P/E Growth Rating (99) in the Servicestothe Health Industry industry is in the same range as BHVN (100) in the Pharmaceuticals Major industry. This means that PLX’s stock grew similarly to BHVN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHVNPLX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEXOY14.580.33
+2.32%
Nexon Co Ltd.
ASHTY255.220.72
+0.28%
Ashtead Group PLC
TRWAX20.45N/A
N/A
Transamerica International Equity A
UBSFY2.54-0.01
-0.39%
UbiSoft Entertainment Inc.
BBBXF0.05N/A
-3.31%
Brixton Metals Corp.

BHVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with XENE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
+2.60%
XENE - BHVN
44%
Loosely correlated
-0.54%
VCYT - BHVN
43%
Loosely correlated
+4.66%
ACLX - BHVN
42%
Loosely correlated
+0.56%
APGE - BHVN
40%
Loosely correlated
+1.47%
SYRE - BHVN
39%
Loosely correlated
+3.29%
More

PLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLX has been loosely correlated with MNKD. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PLX jumps, then MNKD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLX
1D Price
Change %
PLX100%
+1.15%
MNKD - PLX
36%
Loosely correlated
+8.73%
PCVX - PLX
34%
Loosely correlated
+0.42%
NTLA - PLX
33%
Poorly correlated
+1.08%
BHVN - PLX
32%
Poorly correlated
+2.60%
BEAM - PLX
31%
Poorly correlated
+8.16%
More